Skip to content

Intervention phase of the Tehran Lipid and Glucose Study (TLGS phase II)

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study Phase II

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52588395
Enrollment
15005
Registered
2008-11-27
Start date
1999-03-01
Completion date
Unknown
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-communicable diseases (NCD) Not Applicable

Interventions

Primary, secondary and tertiary interventions were designed based on specific target groups including school children, housewives, and high-risk persons. Officials of various sectors such as health, e

Sponsors

Research Institute for Endocrine Sciences (Iran)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals aged 3 years and over, either sex 2. Residents of the District 13 of Tehran 3. Under the coverage of three medical health centres, selected using multistage cluster random sampling method 4. Agree for all members of each family, including those not having risk factors, to be enrolled

Exclusion criteria

Exclusion criteria: Mentally disabled persons

Design outcomes

Primary

MeasureTime frame
Major NCD risk factors including the following: 1. Glucose disorders (oral glucose tolerance test, fasting blood sugar) 2. Dyslipidaemia: serum total cholesterol, triglycerides, low density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) 3. Obesity: a body mass index (BMI) of 25 to 29.9 kg/m^2 in adults is considered as overweight and a BMI equal to or more than 30 kg/m^2 is defined as obesity. Obesity and overweight in children and adolescents are defined according to international cut-off points for body mass index. Truncal obesity is defined as a waist-hip ratio (WHR) more than 0.95 in adult men and more than 0.8 in adult women. 4. Smoking, assessed by a 110-item questionnaire and Modifiable Activity Questionnaire (MAQ) 5. Hypertension (HTN) 6. Level of physical activity, assessed by a 110-item questionnaire and Modifiable Activity Questionnaire (MAQ) 7. Nutritional status, assessed by interviews The primary outcomes are assessed every 3 years.

Secondary

MeasureTime frame
1. Any significant medical events 2. Mortality The secondary outcomes are assessed annually.

Countries

Iran

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026